T2 Biosystems, Inc.
TTOODelisted Jul 10, 2025- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001492674
T2 Biosystems, Inc. was delisted on Jul 10, 2025; its insiders filed their last Form 4 on Jan 2, 2025; 1 institution reported holding it in 13F filings for Q2 2025, worth $0 in total; no superinvestor held it.
Q3 2023 vs. Q2 2023
How the institutions holding T2 Biosystems, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 32 | 1 | 44 | +13 |
| Shares | 6.42M | 1.68K | 18.6M | +12.2M (+190.2%) |
| Value | $451.5K | $119 | $4.06M | +$3.61M (+798.8%) |
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (23)
Institutions that held T2 Biosystems, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vanguard Group Inc | 5,882,163 | $1.30M | 0.00% |
| Two Sigma Securities, LLC | 251,756 | $55.6K | 0.00% |
| Tudor Investment Corp Et Al | 190,926 | $42.2K | 0.00% |
| XTX Topco Ltd | 147,838 | $32.7K | 0.01% |
| Patriot Financial Group Insurance Agency, LLC | 127,234 | $28.1K | 0.01% |
| Level Four Advisory Services, LLC | 110,000 | $24.3K | 0.00% |
| Invst, LLC | 35,000 | $7.73K | 0.00% |
| CWM, LLC | 31,000 | $7.00K | 0.00% |
| Victory Capital Management Inc | 31,137 | $6.88K | 0.00% |
| Wolverine Trading, LLC | 30,035 | $6.63K | 0.00% |
| Continuum Advisory, LLC | 20,478 | $4.52K | 0.00% |
| Squarepoint Ops LLC | 14,925 | $3.30K | 0.00% |
| Brinker Capital Investments, LLC | 12,613 | $2.79K | 0.00% |
| Orion Portfolio Solutions, LLC | 12,613 | $2.79K | 0.00% |
| Avantax Planning Partners, Inc. | 10,205 | $2.25K | 0.00% |
| Copperwynd Financial, LLC | 10,000 | $2.21K | 0.00% |
| Cambridge Investment Research Advisors, Inc. | 10,360 | $2.00K | 0.00% |
| Citadel Advisors LLC | 1,000 | $221 | 0.00% |
| JJJ Advisors Inc. | 900 | $199 | 0.00% |
| Headinvest, LLC | 7 | $2 | 0.00% |
| Cornerstone Planning Group LLC | 8 | $2 | 0.00% |
| Qube Research & Technologies Ltd | 2 | $0 | 0.00% |
| Banco Santander, S.A. | 189,134 | – | – |
Sold out (10)
Institutions that held T2 Biosystems, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Acadian Asset Management LLC | 953,656 | $67.0K |
| Sabby Management, LLC | 448,900 | $31.7K |
| IHT Wealth Management, LLC | 200,900 | $14.2K |
| Cubist Systematic Strategies, LLC | 168,137 | $11.9K |
| Warberg Asset Management LLC | 20,000 | $1.41K |
| WealthPLAN Partners, LLC | 506 | $36 |
| Founders Capital Management | 200 | $14 |
| RFP Financial Group LLC | 40 | $3 |
| First Manhattan Co | 8 | $0 |
| Simplex Trading, LLC | 4,275 | $0 |
Not filed for Q3 2023 yet (1)
Institutions that held T2 Biosystems, Inc. at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Cowen Prime Advisors LLC | 1,684 | $119 |